Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,945,966
-
Share change
-
-18,645,319
-
Total reported value
-
$11,048,651
-
Put/Call ratio
-
16%
-
Price per share
-
$0.40
-
Number of holders
-
49
-
Value change
-
-$24,486,441
-
Number of buys
-
21
-
Number of sells
-
38
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q4 2022
As of 31 Dec 2022,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,945,966 shares.
The largest 10 holders included
TRV GP IV, LLC, Atlas Venture Life Science Advisors, LLC, Alphabet Inc., Deep Track Capital, LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, Laurion Capital Management LP, and BlackRock Inc..
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.